Medicure Inc. (TSXV: MPH)
Canada
· Delayed Price · Currency is CAD 0.980
-0.010 (-1.01%)
Nov 29, 2024, 10:05 AM EST
Medicure Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 21.08 | 21.69 | 23.07 | 21.74 | 11.61 | 20.17 | Upgrade
|
| Revenue Growth (YoY) | -8.09% | -5.94% | 6.08% | 87.29% | -42.45% | -30.70% | Upgrade
|
| Cost of Revenue | 9.07 | 7.71 | 6.99 | 9.03 | 6.48 | 7.27 | Upgrade
|
| Gross Profit | 12.01 | 13.99 | 16.08 | 12.71 | 5.13 | 12.9 | Upgrade
|
| Selling, General & Admin | 12.81 | 12.44 | 11.91 | 13.11 | 10.38 | 16.79 | Upgrade
|
| Research & Development | 3.04 | 2.41 | 2.75 | 1.8 | 3.3 | 4.35 | Upgrade
|
| Operating Expenses | 15.85 | 14.84 | 14.88 | 15.21 | 13.68 | 21.14 | Upgrade
|
| Operating Income | -3.83 | -0.85 | 1.19 | -2.5 | -8.55 | -8.24 | Upgrade
|
| Interest Expense | -0.03 | -0.05 | -0.03 | -0.07 | -0.07 | -0.05 | Upgrade
|
| Interest & Investment Income | 0.18 | 0.08 | 0.01 | 0.08 | 0.04 | 0.89 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.12 | -0.11 | 0.05 | 0.03 | 0.5 | -2.57 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0.04 | -0.19 | -0.36 | 0.8 | -3.35 | Upgrade
|
| EBT Excluding Unusual Items | -3.8 | -0.9 | 1.04 | -2.81 | -7.28 | -13.32 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.42 | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -6.32 | Upgrade
|
| Other Unusual Items | - | - | 0.35 | 2.05 | 0.85 | - | Upgrade
|
| Pretax Income | -1.94 | -0.9 | 1.39 | -0.76 | -6.85 | -19.64 | Upgrade
|
| Income Tax Expense | 0.1 | 0.03 | 0.02 | -0.03 | - | 0.15 | Upgrade
|
| Earnings From Continuing Operations | -2.03 | -0.92 | 1.37 | -0.73 | -6.85 | -19.79 | Upgrade
|
| Net Income | -2.03 | -0.92 | 1.37 | -0.73 | -6.85 | -19.79 | Upgrade
|
| Net Income to Common | -2.03 | -0.92 | 1.37 | -0.73 | -6.85 | -19.79 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 11 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 11 | 15 | Upgrade
|
| Shares Change (YoY) | -8.45% | - | 1.80% | -4.15% | -28.69% | -9.45% | Upgrade
|
| EPS (Basic) | -0.19 | -0.09 | 0.13 | -0.07 | -0.64 | -1.32 | Upgrade
|
| EPS (Diluted) | -0.20 | -0.09 | 0.13 | -0.07 | -0.64 | -1.32 | Upgrade
|
| Free Cash Flow | -0.01 | 2.08 | 1.81 | 3.61 | -2.24 | -14.83 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.20 | 0.17 | 0.35 | -0.21 | -0.99 | Upgrade
|
| Gross Margin | 56.98% | 64.48% | 69.69% | 58.46% | 44.19% | 63.95% | Upgrade
|
| Operating Margin | -18.19% | -3.94% | 5.17% | -11.47% | -73.61% | -40.86% | Upgrade
|
| Profit Margin | -9.65% | -4.25% | 5.92% | -3.34% | -58.96% | -98.08% | Upgrade
|
| Free Cash Flow Margin | -0.02% | 9.58% | 7.86% | 16.61% | -19.31% | -73.50% | Upgrade
|
| EBITDA | -2.15 | 0.93 | 2.87 | 0.65 | -5.77 | -6.32 | Upgrade
|
| EBITDA Margin | -10.19% | 4.30% | 12.46% | 2.99% | -49.72% | -31.32% | Upgrade
|
| D&A For EBITDA | 1.69 | 1.79 | 1.68 | 3.15 | 2.77 | 1.92 | Upgrade
|
| EBIT | -3.83 | -0.85 | 1.19 | -2.5 | -8.55 | -8.24 | Upgrade
|
| EBIT Margin | -18.19% | -3.94% | 5.17% | -11.47% | -73.61% | -40.86% | Upgrade
|
| Effective Tax Rate | - | - | 1.44% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.